Clinical Therapeutics
Clinical Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 153. It has an SJR impact factor of 0,978 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,978.
Clinical Therapeutics focuses its scope in these topics and keywords: healthy, patients, pharmacokinetics, review, treatment, chinese, administered, drug, combination, gastrointestinal, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
0,978
H-index
153
Docs (year)
202
Docs 3y
561
Total refs
6978
Cites 3y
1709
Citable 3y
470
Cites/Doc 2y
3.02
Ref/Doc
34.54
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe
View moreViscosupplementation with Hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee
View moreDisease management contracting: legal issues
View moreCompliance of pediatric patients with treatment involving antibiotic suspensions: A pilot study
View moreComparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy
View moreComparative bioavailability of ceftibuten in capsule and suspension forms
View moreCombined metformin and insulin therapy for patients with type 2 diabetes mellitus
View moreCombination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain
View moreClinical efficacy of dirithromycin in patients with bacteremic pneumonia
View moreCerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness
View moreAzelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone
View moreAzelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients
View moreAssessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension
View moreA cost-of-illness study of lyme disease in the United States
View moreAssessing the input costs of disease management programs
View moreAn outpatient prescription-medication benefit in medicare: So much time, so little consensus
View moreAn immunophilin-binding assay for sirolimus
View moreAn estradiol matrix transdermal system for the prevention of postmenopausal bone loss
View moreAmlodipine, felodipine, and isradipine in the treatment of chinese patients with mild-to-moderate hypertension
View moreA randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients
View moreA randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy
View moreA multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients
View moreA long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia
View moreA disease management case study on asthma
View more